Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
major
products
Chemicals Products
Chemicals Products
An overall factory construction area of 250,000 square meters under international standard to offer flexible, scalable and cost-effective solutions.
Pharmaceutical Ingredients
Pharmaceutical Ingredients
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Documents and Certificates are supported to customers worldwide.
Development
Development
Procurement Service
Procurement Service
For those clients who prefer to avoid the complexity of dealing with multiple points of contact, we provide extra customized procurement services with the most superior and comprehensive supply chain sources.
about
Gentolex
Gentolex’s goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa. Our main services focus on supplying peptides APIs and Custom Peptides, FDF license out, Technical Support & Consultation, Product Line and Lab Setup, Sourcing & Supply Chain Solutions.
news and information
Tirzepatide Injection for Diabetes and Weight Loss
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed. Its dual mechanism aims to enhance insulin secretion, suppress glucagon release, delay gastric emptying, and improve satiety, offering a comprehensive the...
What is PT-141?
Indication (approved use): In 2019, the FDA approved it for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women when the condition causes marked distress and is not due to other medical/psychiatric conditions or drug side effects. Mechanism of Ac...
Phase 2 Clinical Trial of Retatrutide, a Triple Hormone-Receptor Agonist, for the Treatment of Obesity
Background and Study Design Retatrutide (LY3437943) is a novel single-peptide drug that activates three receptors simultaneously: GIP, GLP-1, and glucagon. To evaluate its efficacy and safety in individuals with obesity but without diabetes, a phase 2, randomized, double-blind, placebo-controlled...
What is BPC-157
Full name: Body Protection Compound-157, a pentadecapeptide (15-amino acid peptide) originally isolated from human gastric juice. Amino acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, molecular weight ≈ 1419.55 Da. Compared with many other peptides, BPC-157 is re...
Higher doses of semaglutide can safely improve weight loss for adults living with obesity, clinical trials confirm
Clinical trials have confirmed that higher doses of Semaglutide can safely and effectively help adults with obesity achieve significant weight reduction. This finding offers a new therapeutic approach to the growing global obesity epidemic. Background Semaglutide is a GLP-1 receptor agonist origi...